SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc. (NYSEAM: CLDI) (or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced ...
Log-in to bookmark & organize content - it's free! Cumberland University history professor Mark Cheathem provided a brief overview of the early months of President Andrew Jackson's first term in 1829.